AXSM - Axsome Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AXSM is currently covered by 14 analysts with an average price target of $153.15. This is a potential upside of $48.18 (45.9%) from yesterday's end of day stock price of $104.97.

Axsome Therapeutics's activity chart (see below) currently has 179 price targets and 203 ratings on display. The stock rating distribution of AXSM is 96% BUY and 4% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.66% with an average time for these price targets to be met of 320.45 days.

Highest price target for AXSM is $216, Lowest price target is $105, average price target is $156.67.

Most recent stock forecast was given by VIKRAM PUROHIT from MORGAN STANLEY on 03-Jul-2025. First documented stock forecast 19-May-2017.

Currently out of the existing stock ratings of AXSM, 96 are a BUY (96%), 4 are a HOLD (4%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$190

$78.3 (70.10%)

$190

21 days ago
(03-Jul-2025)

19/21 (90.48%)

$84.56 (80.20%)

356

Buy

$180

$68.3 (61.15%)

$180

1 months 14 days ago
(10-Jun-2025)

6/40 (15%)

$70.09 (63.77%)

108

Buy

$150

$38.3 (34.29%)

$153

1 months 15 days ago
(09-Jun-2025)

8/13 (61.54%)

$40.13 (36.52%)

98

Buy

$162

$50.3 (45.03%)

$160

2 months 18 days ago
(06-May-2025)

2/4 (50%)

$49.84 (44.44%)

181

Buy

$216

$104.3 (93.38%)

$212

3 months 27 days ago
(27-Mar-2025)

18/21 (85.71%)

$94.23 (77.38%)

229

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AXSM (Axsome Therapeutics) average time for price targets to be met?

On average it took 320.45 days on average for the stock forecasts to be realized with a an average price target met ratio 73.66

Which analyst has the current highest performing score on AXSM (Axsome Therapeutics) with a proven track record?

JOSEPH THOME

Which analyst has the most public recommendations on AXSM (Axsome Therapeutics)?

Joseph Thome works at TD COWEN and has 7 price targets and 3 ratings on AXSM

Which analyst is the currently most bullish on AXSM (Axsome Therapeutics)?

Matthew Kaplan with highest potential upside - $105.78

Which analyst is the currently most reserved on AXSM (Axsome Therapeutics)?

Marc Goodman with lowest potential downside - -$26.7

Axsome Therapeutics in the News

Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will host its Frontiers in Brain Health R&D Day on July 21, 2025, starting at 11:00 a.m. Eastern Time in New York City. The...

Analysts Are Updating Their Axsome Therapeutics, Inc. (NASDAQ:AXSM) Estimates After Its First-Quarter Results

The quarterly results for Axsome Therapeutics, Inc. (NASDAQ:AXSM) were released last week, making it a good time to revisit its performance. Revenue hit US$121m in line with forecasts, although the company reported a statutory loss per share of US$1.22 that was somewhat smaller than the analysts expected. This is an important time for investors, as...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?